Biostax Corp (BTAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 437 | 494 | 29 | 23 | 12 |
| Marketable Securities | 362 | 2,645 | 2,657 | N/A | N/A |
| TOTAL | $799 | $3,139 | $2,686 | $23 | $12 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $0 |
| Total Assets | $799 | $3,139 | $2,686 | $23 | $12 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,171 | 2,185 | 2,183 | 2,584 | 2,711 |
| Accrued Expenses | 4,366 | 4,225 | 4,135 | 4,370 | 4,349 |
| Other current liabilities | 716 | 1,607 | 1,041 | 856 | 626 |
| TOTAL | $11,304 | $11,087 | $10,430 | $10,880 | $10,756 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $11,304 | $11,087 | $10,430 | $10,880 | $10,756 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 484 | 484 | 482 | 482 | 482 |
| Retained earnings | -381,989 | -379,432 | -379,228 | -382,341 | -382,228 |
| Other shareholders' equity | 10 | 10 | 10 | 10 | 10 |
| TOTAL | $-10,505 | $-7,948 | $-7,744 | $-10,857 | $-10,744 |
| Total Liabilities And Equity | $799 | $3,139 | $2,686 | $23 | $12 |